Statistics for First-Line Anti-Egfr Agents (panitumumab or Cetuximab) Plus Chemotherapy in Patients With Metastatic Colorectal Cancer: Onco-Colon Turkey Study Subgroup Analysis
Total visits
| views | |
|---|---|
| First-Line Anti-Egfr Agents (panitumumab or Cetuximab) Plus Chemotherapy in Patients With Metastatic Colorectal Cancer: Onco-Colon Turkey Study Subgroup Analysis | 3 |
Total visits per month
| views | |
|---|---|
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 2 |
| April 2026 | 1 |
File Visits
| views | |
|---|---|
| 66.pdf | 5 |
Top country views
| views | |
|---|---|
| Germany | 1 |
| Turkey | 1 |
| United States | 1 |
Top city views
| views | |
|---|---|
| Kayseri | 1 |
| Kelsterbach | 1 |